leisure time -WSS

leisure time

author：hotspot 2025-09-28 04:58:40 - browse：22

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

WSS

Medicare Advantage's lean provider networks lead CMS complaints

STAT Readout Newsletter: Today in biotech, life science news

Structure Therapeutics oral GLP

Nick Jonas talks about managing diabetes along with his career

Better Therapeutics data on benefit with GLP

European regulators recommend Amylyx's ALS drug be rejected

hotspot

leisure time

Wikipedia

Medical records are filled with copy

Senators tussle over abortion against the backdrop of a presidential campaign

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How clinical AI models' predictive power can degrade over time

Hepatitis C has a cure — but many Americans still lack access to it

Life sciences deals on track to hit lowest point since 2017

The cancer drug shortage isn’t new — and neither are the solutions

Humana CEO Bruce Broussard to step down in 2024

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Humana CEO Bruce Broussard to step down in 2024

leisure time

Researchers CRISPR chickens in bid to protect them from bird flu

European regulators recommend Amylyx's ALS drug be rejected

FTC loses bid to block Novant's North Carolina hospital merger

European regulators consider appeal over Amylyx ALS drug

ASCO Daily Recap: CAR

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Wikipedia

entertainment

Wikipedia

entertainment